Medical Oncology

OCT 26, 2026 · JOURNAL ARTICLE

Cannabidiol impairs tumor-associated behaviors and modulates apoptosis- and autophagy-related pathways in cisplatin-resistant head and neck squamous cell carcinoma

Medical Oncology

Head and neck squamous cell carcinoma (HNSCC) remains a challenge due to recurrence, metastasis, and resistance to conventional therapies, particularly in human papillomavirus (HPV

OCT 8, 2026 · JOURNAL ARTICLE

Antitumor efficacy and safety profile of gallic acid in the murine sarcoma 180 model

Medical Oncology

Abstract Gallic acid (GA) is a plant-derived polyphenol with recognized anticancer activity, but in vivo evidence, especially in mesenchymal solid tumors, remains limited. This stu

OCT 3, 2026 · REVIEW

The impact of intratumor heterogeneity on outcome and resistance to therapy in primary breast cancer: a systematic review

Medical Oncology

Abstract Intratumor heterogeneity (ITH), the coexistence of diverse subclones within a single tumor, may pose a major challenge to effective chemotherapy in breast cancer. This cel

SEP 25, 2026 · JOURNAL ARTICLE

Ketogenic diet as a systems-level immunometabolic sensitization strategy in cancer therapy: integrating metabolism, immune reprogramming, microbiome dynamics, and epigenetic regulation

Medical Oncology

Abstract The ketogenic diet (KD) is increasingly being recognized as more than a simple metabolic intervention in cancer therapy. Emerging evidence suggests that KD may function as

AUG 7, 2026 · REVIEW

Genomic, transcriptomic, and molecular predictors of response to neoadjuvant therapy in locally advanced rectal cancer: a narrative review

Medical Oncology

A narrative review synthesizing current evidence on genomic and molecular biomarkers for neoadjuvant therapy response in rectal cancer, offering recommendations for future clinical integration without reporting original trial data.